Westlake Chemical Partners

Westlake Chemical Partners reported Q2 net income of $14 million ($0.40/unit) and distributable cash flow of $18 million ($0.50/unit), supporting a quarterly distribution of $0.4714 per unit and a trailing 12-month coverage ratio of 1.04x. Management said the fixed-margin Ethylene Sales Agreement with Westlake continues to insulate margins from market volatility, while consolidated net sales were $297 million and consolidated cash totaled $93 million. The partnership extended revolving credit agreements through 2031 at a lower rate, outlined four growth avenues (higher OpCo ownership, acquisitions, facility expansion, or higher fixed margin) and announced a CFO transition as Steve Bender retires and John Bochert assumes the role. » More on finance.yahoo.com

Westlake Chemical Partners reported Q2 2026 earnings of $0.40 per share on revenue of $297.1 million, missing the revenue estimate significantly ($537 million). Distributable cash flow rose 20% year over year to $18 million ($0.50 per share), while net income remained steady at $14 million. The stock showed little movement in premarket trading and was last quoted at $21.30. » More on de.investing.com

Westlake Chemical Partners reports Q1 2026 EPS of $0.40, net income of $82 million and revenues of $306 million, thereby meeting analysts' expectations. Net income rose 64% year‑over‑year, supported by higher production and sales volumes and the end of maintenance at the Petro‑1 facility. The distribution was maintained for the 47th consecutive time; management expects stable cash flows in 2026 without major maintenance and benefits from higher ethylene prices in North America. » More on de.investing.com